Researchers report ApoE4 can reduce the number of functional synapses by interfering with the DNA responsible for synapse formation and maintenance.
Buphenyl (sodium phenylbutyrate), a medication approved for the treatment of hyperammonemia, could help prevent the progression of Alzheimer's disease, a new study finds.
